BioLife Solutions BLFS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.19M— | —— | $621K+104% | -$15.84M-3,435% | -$448K— | ||
| $374K+43.3% | $261K-59.0% | $636K-5.6% | $674K-1.2% | $682K-27.2% | ||
| $4.81M-32.1% | $7.08M+19.9% | $5.9M+0.8% | $5.86M+41.1% | $4.15M-61.2% | ||
| $9K— | $0-100% | $14K-68.9% | $45K+650% | $6K— | ||
| $5.1M+363% | -$1.94M-348% | $782K-12.4% | $893K+89,400% | -$1K-100% | ||
| $2.68M+14.9% | $2.33M— | —— | —— | -$1.45M— | ||
| $2.21M+332% | -$952K-40.2% | -$679K— | —— | -$828K-171% | ||
| -$4.4M— | —— | —— | —— | -$4.25M-160% | ||
| $26K-90.2% | $264K— | $0+100% | -$16K-200% | $16K— | ||
| -$148K+89.3% | -$1.39M— | $0+100% | -$298K+8.9% | -$327K-289% | ||
| -$491K-110% | $4.92M-19.5% | $6.1M-17.2% | $7.37M+327% | $1.73M+5.0% | ||
| $167K-98.2% | $9.03M+2,408% | $360K— | $0-100% | $175K-94.4% | ||
| $20.43M-44.3% | $36.67M+180% | $13.09M-61.5% | $33.98M+12.1% | $30.32M+1,163% | ||
| $2.33M-28.0% | $3.24M+76.4% | $1.84M+55.3% | $1.18M+106% | $573K-37.0% | ||
| —— | $5.88M0.0% | $5.88M0.0% | $5.88M0.0% | $5.88M-68.0% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| -$1.83M— | $0+100% | -$5.97M+84.9% | -$39.53M-45.5% | -$27.18M-137% | ||
| $190K+1,156% | -$18K— | $0-100% | $18K— | $0+100% | ||
| $5.59M— | —— | —— | —— | $0— | ||
| $3K-25.0% | $4K-55.6% | $9K-10.0% | $10K0.0% | $10K+117% | ||
| -$7.9M-216% | -$2.5M+2.4% | -$2.56M+11.1% | -$2.88M+3.8% | -$2.99M+26.8% | ||
| -$10.22M— | $0+100% | -$2.42M+93.1% | -$35.04M-23.2% | -$28.44M-140% | ||
| $73K-38.1% | $118K-28.0% | $164K-23.7% | $215K-18.9% | $265K-28.8% | ||
| $122K-39.3% | $201K-12.6% | $230K+15.0% | $200K+90.5% | $105K+56.7% | ||
| $325K0.0% | $325K-53.5% | $699K-1.3% | $708K+0.9% | $702K-8.5% | ||
| $0— | $0+100% | -$167K-7.1% | -$156K+16.6% | -$187K-71.6% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $2.58M0.0% | $2.58M0.0% | $2.58M0.0% | $2.58M-35.0% | ||
| -$4.4M— | —— | —— | —— | -$4.25M-160% | ||
| -$148K+89.3% | -$1.39M— | $0+100% | -$298K+8.9% | -$327K-289% | ||
| -$3.22M-797% | $462K-84.6% | $3M+1,340% | -$242K-33.7% | -$181K-105% | ||
| —— | $468.75K0.0% | $468.75K0.0% | $468.75K0.0% | $468.75K+342% | ||
| -$188K— | —— | $1.32M+270% | $358K+14.7% | $312K— | ||
| $16.44M+6.6% | $15.41M+40.6% | $10.96M+103% | $5.39M+79.7% | $3M+7.1% | ||
| $0-100% | $101K-72.9% | $373K+130% | $162K-35.2% | $250K+525% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $2.33M-28.0% | $3.24M+76.4% | $1.84M+55.3% | $1.18M+106% | $573K-37.0% | ||
| $3K-25.0% | $4K-55.6% | $9K-10.0% | $10K0.0% | $10K+117% | ||
| $0— | $0-100% | $67K-83.5% | $406K-19.1% | $502K-24.7% | ||
| $2.5M0.0% | $2.5M0.0% | $2.5M0.0% | $2.5M0.0% | $2.5M0.0% | ||
| $58K+113% | -$450K-225% | $360K+178% | -$462K-184% | $552K+5,420% | ||
| -$252K-12,700% | $2K-96.6% | $59K+5.4% | $56K+722% | -$9K— | ||
| —— | $0— | $0— | $0— | $0— | ||
| -$658K— | —— | $5.74M-22.9% | $7.45M+380% | $1.55M— | ||
| -$658K— | —— | $5.74M-22.9% | $7.45M+380% | $1.55M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioLife Solutions generate?
- BioLife Solutions (BLFS) generated $17.9M in operating cash flow over the trailing twelve months.
- What is BioLife Solutions's free cash flow?
- After $9.6M of capital expenditures, BioLife Solutions's free cash flow was $14.1M over the trailing twelve months, up 110.7% year over year.
- Where does BioLife Solutions's cash flow data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
